Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic HAdV antigen-specific T lymphocytes

A population of allogeneic T lymphocytes specifically reactive to human adenovirus (HAdV) with potential antiviral activity. Allogeneic HAdV antigen-specific T cells are prepared via ex vivo stimulation of donor-derived peripheral blood mononuclear cells (PBMCs) with HAdV hexon protein. T cells that secrete interferon (IFN)-gamma in response to HAdV antigen exposure are selected and expanded for administration. Infusion of the HAdV antigen-specific T lymphocytes into hematopoietic stem cell transplant (HSCT) patients infected with HAdV may potentially reconstitute virus-specific responses, thereby controlling HAdV infections.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic HAdV antigen-selected T cells
allogeneic HAdV antigen-selected T lymphocytes
allogeneic HAdV antigen-specific T cells
allogeneic human adenovirus-specific T lymphocytes
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search